Literature DB >> 3572549

Imaging of metastases of thyroid carcinoma with fluorine-18 fluorodeoxyglucose.

H Joensuu, A Ahonen.   

Abstract

Three patients with multiple metastases of thyroid carcinoma were studied with 18F-2-fluoro-2-deoxy-D-glucose (FDG) and iodine-131 (131I) imaging. Metastases that accumulated only FDG, only 131I, or both FDG and 131I could be demonstrated. Metabolic heterogeneity was seen between different metastases in all patients. The accumulation of FDG may also differ between different metastases of the same patient. The uptake of FDG in metastases was shown to increase parallel with their progression. Metastases of thyroid carcinoma that have ceased to accumulate 131I after treatment with radioiodine may still be demonstrated with FDG. Metastases that accumulate FDG, but not 131I, may behave more aggressively than metastases that accumulate 131I, but not FDG.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3572549

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  16 in total

Review 1.  An update on diagnostic methods in the investigation of diseases of the thyroid.

Authors:  M J Reinhardt; E Moser
Journal:  Eur J Nucl Med       Date:  1996-05

2.  Two Distant Muscular Metastases from Papillary Carcinoma of the Thyroid Demonstrated by (18)F-FDG PET/CT and Confirmed by Biopsy.

Authors:  Federico Caobelli; Barbara Paghera; Maria Beatrice Panarotto; Luca Camoni; Raffaele Giubbini
Journal:  Nucl Med Mol Imaging       Date:  2011-10-08

Review 3.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

4.  Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma.

Authors:  A Frilling; K Tecklenborg; R Görges; F Weber; M Clausen; E C Broelsch
Journal:  Ann Surg       Date:  2001-12       Impact factor: 12.969

Review 5.  The role of 18F-fluorodeoxyglucose positron emission tomography in thyroid neoplasms.

Authors:  Brian Hung-Hin Lang; Tsz Ting Law
Journal:  Oncologist       Date:  2011-03-04

6.  The value of positron emission tomography in the surgical management of recurrent papillary thyroid carcinoma.

Authors:  Clive S Grant; Geoffrey B Thompson; David R Farley; Melanie L Richards; Brian P Mullan; Ian D Hay
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

7.  Autoradiographic analysis of [14C]deoxy-D-glucose in thyroid cancer xenografts: a comparative study with pathologic correlation.

Authors:  M Kubota; T Tsuda; T Minase; K Nakada; M Furudate
Journal:  Ann Nucl Med       Date:  1994-02       Impact factor: 2.668

8.  [18F]fluorodeoxyglucose scintigraphy in diagnosis and follow up of treatment in advanced breast cancer.

Authors:  H Minn; I Soini
Journal:  Eur J Nucl Med       Date:  1989

Review 9.  Endocrine tumors: the evolving role of positron emission tomography in diagnosis and management.

Authors:  M Naji; M Hodolic; S El-Refai; S Khan; M C Marzola; D Rubello; A Al-Nahhas
Journal:  J Endocrinol Invest       Date:  2009-10-09       Impact factor: 4.256

10.  Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer.

Authors:  F Grünwald; A Schomburg; H Bender; E Klemm; C Menzel; T Bultmann; H Palmedo; J Ruhlmann; B Kozak; H J Biersack
Journal:  Eur J Nucl Med       Date:  1996-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.